These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 32012790)

  • 41. Pathway choice in the alternative telomere lengthening in neoplasia is dictated by replication fork processing mediated by EXD2's nuclease activity.
    Broderick R; Cherdyntseva V; Nieminuszczy J; Dragona E; Kyriakaki M; Evmorfopoulou T; Gagos S; Niedzwiedz W
    Nat Commun; 2023 Apr; 14(1):2428. PubMed ID: 37105990
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Suppression of alternative telomere lengthening in cancer cells with reverse transcriptase inhibitors].
    Bondarev IE; Khavinson VK
    Adv Gerontol; 2016; 29(2):218-221. PubMed ID: 28514537
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Twisted epithelial-to-mesenchymal transition promotes progression of surviving bladder cancer T24 cells with hTERT-dysfunction.
    Xue Y; Li L; Zhang D; Wu K; Chen Y; Zeng J; Wang X; He D
    PLoS One; 2011; 6(11):e27748. PubMed ID: 22110753
    [TBL] [Abstract][Full Text] [Related]  

  • 44. How Do Telomere Abnormalities Regulate the Biology of Neuroblastoma?
    Akter J; Kamijo T
    Biomolecules; 2021 Jul; 11(8):. PubMed ID: 34439779
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Histone demethylase KDM2A is a selective vulnerability of cancers relying on alternative telomere maintenance.
    Li F; Wang Y; Hwang I; Jang JY; Xu L; Deng Z; Yu EY; Cai Y; Wu C; Han Z; Huang YH; Huang X; Zhang L; Yao J; Lue NF; Lieberman PM; Ying H; Paik J; Zheng H
    Nat Commun; 2023 Mar; 14(1):1756. PubMed ID: 36991019
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Evidence for alternative lengthening of telomeres in liposarcomas in the absence of ALT-associated PML bodies.
    Jeyapalan JN; Mendez-Bermudez A; Zaffaroni N; Dubrova YE; Royle NJ
    Int J Cancer; 2008 Jun; 122(11):2414-21. PubMed ID: 18311780
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Alternative lengthening of telomeres (ALT) cells viability is dependent on C-rich telomeric RNAs.
    Rosso I; Jones-Weinert C; Rossiello F; Cabrini M; Brambillasca S; Munoz-Sagredo L; Lavagnino Z; Martini E; Tedone E; Garre' M; Aguado J; Parazzoli D; Mione M; Shay JW; Mercurio C; d'Adda di Fagagna F
    Nat Commun; 2023 Nov; 14(1):7086. PubMed ID: 37925537
    [TBL] [Abstract][Full Text] [Related]  

  • 48. SLX4IP Promotes Telomere Maintenance in Androgen Receptor-Independent Castration-Resistant Prostate Cancer through ALT-like Telomeric PML Localization.
    Mangosh TL; Awadallah WN; Grabowska MM; Taylor DJ
    Mol Cancer Res; 2021 Feb; 19(2):301-316. PubMed ID: 33188147
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Loss of wild-type ATRX expression in somatic cell hybrids segregates with activation of Alternative Lengthening of Telomeres.
    Bower K; Napier CE; Cole SL; Dagg RA; Lau LM; Duncan EL; Moy EL; Reddel RR
    PLoS One; 2012; 7(11):e50062. PubMed ID: 23185534
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Alternative lengthening of telomeres: mechanism and the pathogenesis of cancer.
    Mori JO; Keegan J; Flynn RL; Heaphy CM
    J Clin Pathol; 2024 Jan; 77(2):82-86. PubMed ID: 37890990
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Telomere recombination and alternative telomere lengthening mechanisms.
    Draskovic I; Londono Vallejo A
    Front Biosci (Landmark Ed); 2013 Jan; 18(1):1-20. PubMed ID: 23276906
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Different telomere maintenance mechanisms in alveolar and embryonal rhabdomyosarcoma.
    Ohali A; Avigad S; Naumov I; Goshen Y; Ash S; Yaniv I
    Genes Chromosomes Cancer; 2008 Nov; 47(11):965-70. PubMed ID: 18663749
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Induction of the alternative lengthening of telomeres pathway by trapping of proteins on DNA.
    Rose AM; Goncalves T; Cunniffe S; Geiller HEB; Kent T; Shepherd S; Ratnaweera M; O'Sullivan RJ; Gibbons RJ; Clynes D
    Nucleic Acids Res; 2023 Jul; 51(13):6509-6527. PubMed ID: 36940725
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Presence of alternative lengthening of telomeres associated circular extrachromosome telomere repeats in primary leukemia cells of chronic myeloid leukemia.
    Samassekou O; Malina A; Hébert J; Yan J
    J Hematol Oncol; 2013 Apr; 6():26. PubMed ID: 23547895
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Alternative lengthening of telomeres is the major telomere maintenance mechanism in astrocytoma with isocitrate dehydrogenase 1 mutation.
    Ferreira MSV; Sørensen MD; Pusch S; Beier D; Bouillon AS; Kristensen BW; Brümmendorf TH; Beier CP; Beier F
    J Neurooncol; 2020 Mar; 147(1):1-14. PubMed ID: 31960234
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Telomere Maintenance Mechanisms Define Clinical Outcome in High-Risk Neuroblastoma.
    Koneru B; Lopez G; Farooqi A; Conkrite KL; Nguyen TH; Macha SJ; Modi A; Rokita JL; Urias E; Hindle A; Davidson H; Mccoy K; Nance J; Yazdani V; Irwin MS; Yang S; Wheeler DA; Maris JM; Diskin SJ; Reynolds CP
    Cancer Res; 2020 Jun; 80(12):2663-2675. PubMed ID: 32291317
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Alternative Lengthening of Telomeres and Chromatin Status.
    Udroiu I; Sgura A
    Genes (Basel); 2019 Dec; 11(1):. PubMed ID: 31905921
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Life and cancer without telomerase: ALT and other strategies for making sure ends (don't) meet.
    Apte MS; Cooper JP
    Crit Rev Biochem Mol Biol; 2017 Feb; 52(1):57-73. PubMed ID: 27892716
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Telomerase activity in pleural malignant mesotheliomas.
    Au AY; Hackl T; Yeager TR; Cohen SB; Pass HI; Harris CC; Reddel RR
    Lung Cancer; 2011 Sep; 73(3):283-8. PubMed ID: 21277646
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effect of silencing key proteins in telomerase mechanism and alternative lengthening of telomeres mechanism in laryngeal cancer cells.
    Xu Y; Wang X; Chen SM; Chen C; Wang Y; Xiao BK; Tao ZZ
    Am J Otolaryngol; 2016; 37(6):552-558. PubMed ID: 27726944
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.